 |
PDBsum entry 2mjw
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein/metal binding protein
|
PDB id
|
|
|
|
2mjw
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Plos One
9:e103947
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
|
|
S.R.Penumutchu,
R.H.Chou,
C.Yu.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The S100P protein is a member of the S100 family of calcium-binding proteins and
possesses both intracellular and extracellular functions. Extracellular S100P
binds to the cell surface receptor for advanced glycation end products (RAGE)
and activates its downstream signaling cascade to meditate tumor growth, drug
resistance and metastasis. Preventing the formation of this S100P-RAGE complex
is an effective strategy to treat various disease conditions. Despite its
importance, the detailed structural characterization of the S100P-RAGE complex
has not yet been reported. In this study, we report that S100P preferentially
binds to the V domain of RAGE. Furthermore, we characterized the interactions
between the RAGE V domain and Ca(2+)-bound S100P using various biophysical
techniques, including isothermal titration calorimetry (ITC), fluorescence
spectroscopy, multidimensional NMR spectroscopy, functional assays and
site-directed mutagenesis. The entropy-driven binding between the V domain of
RAGE and Ca(+2)-bound S100P was found to lie in the micromolar range (Kd of ∼
6 µM). NMR data-driven HADDOCK modeling revealed the putative sites that
interact to yield a proposed heterotetrameric model of the S100P-RAGE V domain
complex. Our study on the spatial structural information of the proposed
protein-protein complex has pharmaceutical relevance and will significantly
contribute toward drug development for the prevention of RAGE-related
multifarious diseases.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|